Zobrazeno 1 - 10
of 64
pro vyhledávání: '"K. Sennfält"'
Autor:
Becky Pennington, Andrew S. Kennedy, Bruno Sangro, Lourens Bester, Ron Akehurst, K Sennfält, Harpreet Wasan
Publikováno v:
Journal of Medical Economics. 18:797-804
Selective internal radiation therapy (SIRT) using SIR-Spheres(®) (90)Y-labeled resin microspheres has been shown to be a well-tolerated, effective treatment in patients with inoperable liver-dominant chemotherapy-refractory metastatic colorectal can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9cee24d94642f51f90b57b03ed0899d
https://doi.org/10.3111/13696998.2015.1047779
https://doi.org/10.3111/13696998.2015.1047779
Autor:
K. Sennfält, Hayley Bennett, Keshwar Baboolal, Javier Sabater, Phil McEwan, George Chamberlain, Rhys Pockett
Publikováno v:
Transplantation. 97:854-861
Background. This study aims to describe the healthcare resource utilization and costs of managing renal posttransplant patients over 3 years posttransplant in nine European countries and to stratify them by year 1 glomerular filtration rate (GFR). Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::debe8d00fedb3b8c2c586afb9396c2c5
https://doi.org/10.1097/01.tp.0000438205.04348.69
https://doi.org/10.1097/01.tp.0000438205.04348.69
Publikováno v:
Primary Care Diabetes. 6:127-136
Aim The objective of this study was to investigate the cost-effectiveness of saxagliptin (Onglyza ® ), a DPP-4 inhibitor, plus metformin compared with a sulphonylurea (SU) (Glipizide) plus metformin in Swedish patients not well controlled on metform
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::002df8ec8d24652cd79cb250e9e6e736
https://doi.org/10.1016/j.pcd.2011.09.003
https://doi.org/10.1016/j.pcd.2011.09.003
Publikováno v:
Acta Psychiatrica Scandinavica. 124:214-225
Kasteng F, Eriksson J, Sennfalt K, Lindgren P. Metabolic effects and cost-effectiveness of aripiprazole versus olanzapine in schizophrenia and bipolar disorder. Objective: To assess the cost-effectiveness of aripiprazole versus olanzapine in the trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e95e37bff24bf9aa2d42ead266e47af
https://doi.org/10.1111/j.1600-0447.2011.01716.x
https://doi.org/10.1111/j.1600-0447.2011.01716.x
Autor:
Marc van Baardewijk, Kawitha Vardeva, Andrew Davies, Jean-Yves Loze, K. Sennfält, Gilbert L'Italien
Publikováno v:
Current Medical Research and Opinion. 24:3275-3285
To evaluate the cost-effectiveness of atypical antipsychotic treatment sequences for the management of stable schizophrenia in the UK.A Markov model was developed to assess the cost per quality-adjusted life year (QALY) gained from 12 alternative tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a1e18b2804235ba8c7c7836f74e5168
https://doi.org/10.1185/03007990802507547
https://doi.org/10.1185/03007990802507547
Publikováno v:
Scandinavian Journal of Gastroenterology. 36:870-876
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47e747127732af02a53f38b182e73628
https://doi.org/10.1080/00365520120428
https://doi.org/10.1080/00365520120428
Publikováno v:
Value in Health. 16(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5685a0f9ec05990d0d09470d597042c
Publikováno v:
Value in Health. 14(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59b820c4342cc3baa95565f354e7f61d
Publikováno v:
Acta psychiatrica Scandinavica. 124(3)
To assess the cost-effectiveness of aripiprazole versus olanzapine in the treatment of patients with schizophrenia or bipolar disorder in Sweden with focus on the metabolic impact of the treatments.A Markov health-state transition model was developed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4f2225fd66331544024efdfb0c6f2cd7
https://pubmed.ncbi.nlm.nih.gov/21609324
https://pubmed.ncbi.nlm.nih.gov/21609324
Autor:
Aljoscha Neubauer, Benedicte Lescrauwaet, Bart Heeg, Per-Olof Thuresson, Annette Alaeus, K. Sennfält
Publikováno v:
Scandinavian journal of infectious diseases. 43(4)
The aim of this study was to estimate the cost-effectiveness of atazanavir/ritonavir (atazanavir/r) versus lopinavir/ritonavir (lopinavir/r) in treatment-naïve human immunodeficiency virus-1 (HIV-1) patients in Sweden for whom efavirenz is not suita
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4383a599bb06707503ce3a2a739f2cb
https://pubmed.ncbi.nlm.nih.gov/21231811
https://pubmed.ncbi.nlm.nih.gov/21231811